Search Results 391-400 of 17175 for egfr

1. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

   Calculated creatinine clearance ≥ 60 mL/min using the following formula: eGFR × body surface area [BSA]/1.73 m2 (per the National Kidney Foundation eGFR ...

2. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   EGFR TKIs must not be given concomitantly and should be used with caution in the 90 days after the last dose of rilvegostomig. Have had major surgical ...

3. S1406 A Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer - Mayo Clinic

   Cetuximab, panitumumab, or any other monoclonal antibody against EGFR or inhibitor of EGFR; BRAF inhibitor including, but not limited to, vemurafenib or ...

4. Phase 1b Open-Label Study of PEGPH20 With Pembrolizumab - Mayo Clinic

   Subjects with NSCLC who are known to be epidermal growth factor receptor (EGFR)-mutation positive must have received an EGFR inhibitor and subjects known to ...

5. End-stage renal disease - Doctors and departments - Mayo Clinic

   When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

6. INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure - Mayo Clinic

   Renal impairment (eGFR ≤ 60); History of ischemic stroke; History of peripheral artery disease; Current smoking. Exclusion Criteria: Known allergy ...

7. Uterine fibroids - Doctors and departments - Mayo Clinic

   Learn about these common noncancerous growths and what to do if you have symptoms such as heavy menstrual bleeding.

8. A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC - Mayo Clinic

   1. * Adequate bone marrow, liver and kidney function. Exclusion Criteria: * Sensitizing epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma ...

9. Cancer Treatment Clinical Trials - Mayo Clinic Research

   A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer ...

10. Frontotemporal dementia - Doctors and departments - Mayo Clinic

    Mayo Clinic staff actively research frontotemporal dementia and related conditions. Researchers study risk factors, causes, diagnostic techniques and treatment ...